MEMPHIS, Tenn.--(BUSINESS WIRE)--Active Implants, the technology leader in cushion-bearing orthopedics for treatment of osteoarthritis, today announced it has received Investigational Device Exemption (IDE) approval to conduct a pivotal clinical trial of the NUsurface® Meniscus Implant in patients with knee osteoarthritis.
Help employers find you! Check out all the jobs and post your resume.
